Allergy Therapeutics PLC
F:HHU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Allergy Therapeutics PLC
F:HHU
|
UK |
|
H
|
Hera SpA
SWB:HE9
|
IT |
|
S
|
SFC Energy AG
DUS:F3C
|
DE |
|
K
|
Kenilworth Systems Corp
OTC:KENS
|
US |
|
A
|
Applied Therapeutics Inc
F:2UV
|
US |
|
Chennai Petroleum Corporation Ltd
BSE:500110
|
IN |
|
T
|
thyssenkrupp nucera AG & Co KgaA
F:NCH2
|
DE |
|
Eregli Demir ve Celik Fabrikalari TAS
F:EDVA
|
TR |
|
A
|
Acea SpA
XBER:DCA
|
IT |
|
M
|
Mitchells & Butlers PLC
DUS:MABB
|
UK |
|
I
|
Integra Lifesciences Holdings Corp
XMUN:IL3
|
US |
|
Lemonade Inc
LSE:0A91
|
US |
|
S
|
SSP Group PLC
F:83S2
|
UK |
|
Arkema SA
OTC:ARKAF
|
FR |
|
S
|
Shanghai Electric Group Co Ltd
SWB:USR
|
CN |
|
G
|
Genpact Ltd
XBER:35G
|
BM |
Shareholder Yield
Current shareholder yield for 
HHU is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
HHU Price
Allergy Therapeutics PLC
| Average Annual Return | 42.64% |
| Standard Deviation of Annual Returns | 165.46% |
| Max Drawdown | -100% |
| Market Capitalization | 544.1m EUR |
| Shares Outstanding | 4 766 440 000 |
| Percentage of Shares Shorted |
N/A
|
